FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

2459711000001105: Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1882061000001117 Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1882071000001110 Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet Is a Penicillamine 125mg tablets 56 tablet true Inferred relationship Existential restriction modifier
Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet Is pack of Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet Has active ingredient Musculoskeletal system agent false Inferred relationship Existential restriction modifier
Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet Has active ingredient Penicillamine false Inferred relationship Existential restriction modifier
Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet Has AMP Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet Has specific active ingredient Penicillamine true Inferred relationship Existential restriction modifier
Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Penicillamine 125mg tablets (Kent Pharma (UK) Ltd) 56 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start